Recalibration of blood analytes over 25 years in the Atherosclerosis Risk in Communities Study: Impact of recalibration on chronic kidney disease prevalence and incidence
Christina M. Parrinello, Morgan E. Grams, David Couper, Christie M. Ballantyne, Ron C. Hoogeveen, John H. Eckfeldt, Elizabeth Selvin, Josef Coresh
Dive into the research topics of 'Recalibration of blood analytes over 25 years in the Atherosclerosis Risk in Communities Study: Impact of recalibration on chronic kidney disease prevalence and incidence'. Together they form a unique fingerprint.